181 related articles for article (PubMed ID: 11131652)
1. Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats.
de Wilt JH; Soma G; ten Hagen TL; Kanou J; Takagi K; Nooijen PT; Seynhaevel AL; Eggermont AM
Anticancer Res; 2000; 20(5B):3491-6. PubMed ID: 11131652
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor response of interleukin 2 with melphalan in isolated limb perfusion in soft tissue sarcoma-bearing rats.
Hoving S; Brunstein F; aan de Wiel-Ambagtsheer G; van Tiel ST; de Boeck G; de Bruijn EA; Eggermont AM; ten Hagen TL
Cancer Res; 2005 May; 65(10):4300-8. PubMed ID: 15899822
[TBL] [Abstract][Full Text] [Related]
3. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
[TBL] [Abstract][Full Text] [Related]
4. TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects.
van der Veen AH; de Wilt JH; Eggermont AM; van Tiel ST; Seynhaeve AL; ten Hagen TL
Br J Cancer; 2000 Feb; 82(4):973-80. PubMed ID: 10732774
[TBL] [Abstract][Full Text] [Related]
5. Early destruction of tumor vasculature in tumor necrosis factor-alpha-based isolated limb perfusion is responsible for tumor response.
Hoving S; Seynhaeve AL; van Tiel ST; aan de Wiel-Ambagtsheer G; de Bruijn EA; Eggermont AM; ten Hagen TL
Anticancer Drugs; 2006 Sep; 17(8):949-59. PubMed ID: 16940805
[TBL] [Abstract][Full Text] [Related]
6. Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.
de Wilt JH; Manusama ER; van Etten B; van Tiel ST; Jorna AS; Seynhaeve AL; ten Hagen TL; Eggermont AM
Br J Cancer; 2000 Nov; 83(9):1176-82. PubMed ID: 11027431
[TBL] [Abstract][Full Text] [Related]
7. In vivo isolated kidney perfusion with tumour necrosis factor alpha (TNF-alpha) in tumour-bearing rats.
van der Veen AH; Seynhaeve AL; Breurs J; Nooijen PT; Marquet RL; Eggermont AM
Br J Cancer; 1999 Feb; 79(3-4):433-9. PubMed ID: 10027309
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the role of neutrophils on the antitumor effect of TNFalpha in an in vivo isolated limb perfusion model in sarcoma-bearing brown Norway rats.
Manusama ER; Nooijen PT; Stavast J; de Wilt JH; Marquet RL; Eggermont AM
J Surg Res; 1998 Aug; 78(2):169-75. PubMed ID: 9733636
[TBL] [Abstract][Full Text] [Related]
9. Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma.
Pencavel TD; Wilkinson MJ; Mansfield DC; Khan AA; Seth R; Karapanagiotou EM; Roulstone V; Aguilar RJ; Chen NG; Szalay AA; Hayes AJ; Harrington KJ
Int J Cancer; 2015 Feb; 136(4):965-76. PubMed ID: 24978211
[TBL] [Abstract][Full Text] [Related]
10. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan.
Bauer TW; Gutierrez M; Dudrick DJ; Li J; Blair IA; Menon C; Fraker DL
Surgery; 2003 Apr; 133(4):420-8. PubMed ID: 12717360
[TBL] [Abstract][Full Text] [Related]
11. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
[TBL] [Abstract][Full Text] [Related]
12. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
13. Synergistic antitumour effect of recombinant human tumour necrosis factor alpha with melphalan in isolated limb perfusion in the rat.
Manusama ER; Nooijen PT; Stavast J; Durante NM; Marquet RL; Eggermont AM
Br J Surg; 1996 Apr; 83(4):551-5. PubMed ID: 8665257
[TBL] [Abstract][Full Text] [Related]
14. Toxicity and antitumor activity of interferon gamma alone and in combinations with TNFalpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats.
Manusama ER; De Wilt JH; Ten Hagen TL; Marquet RL; Eggermont AM
Oncol Rep; 1999; 6(1):173-7. PubMed ID: 9864423
[TBL] [Abstract][Full Text] [Related]
15. Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha versus toxicity after melphalan alone.
Vrouenraets BC; Eggermont AM; Hart AA; Klaase JM; van Geel AN; Nieweg OE; Kroon BB
Eur J Surg Oncol; 2001 Jun; 27(4):390-5. PubMed ID: 11417986
[TBL] [Abstract][Full Text] [Related]
16. Synergism of tumor necrosis factor-alpha and melphalan in systemic and regional administration: animal study.
Gutman M; Sofer D; Lev-Chelouche D; Merimsky O; Klausner JM
Invasion Metastasis; 1997; 17(4):169-75. PubMed ID: 9778589
[TBL] [Abstract][Full Text] [Related]
17. Complete response of melanoma-in-transit metastasis after isolated limb perfusion with tumor necrosis factor alpha and melphalan without massive tumor necrosis: a clinical and histopathological study of the delayed-type reaction pattern.
Nooijen PT; Eggermont AM; Schalkwijk L; Henzen-Logmans S; de Waal RM; Ruiter DJ
Cancer Res; 1998 Nov; 58(21):4880-7. PubMed ID: 9809994
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion.
de Wilt JH; ten Hagen TL; de Boeck G; van Tiel ST; de Bruijn EA; Eggermont AM
Br J Cancer; 2000 Mar; 82(5):1000-3. PubMed ID: 10737379
[TBL] [Abstract][Full Text] [Related]
19. Isolated limb perfusion for unresectable melanoma of the extremities.
Noorda EM; Vrouenraets BC; Nieweg OE; van Geel BN; Eggermont AM; Kroon BB
Arch Surg; 2004 Nov; 139(11):1237-42. PubMed ID: 15545572
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of TNF-alpha and melphalan in an isolated limb perfusion model of rat sarcoma: a histopathological, immunohistochemical and electron microscopical study.
Nooijen PT; Manusama ER; Eggermont AM; Schalkwijk L; Stavast J; Marquet RL; de Waal RM; Ruiter DJ
Br J Cancer; 1996 Dec; 74(12):1908-15. PubMed ID: 8980389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
